Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
NEWGEN.NS Stock Summary
Top 10 Correlated ETFs
NEWGEN.NS
In the News
NEWGEN.NS Financial details
Company Rating
Neutral
Market Cap
108.61B
Income
2.25B
Revenue
11.74B
Book val./share
-
Cash/share
-
Dividend
10
Dividend %
0.65%
Employees
3.87K
Optionable
No
Shortable
Yes
Earnings
30 Apr 2024
P/E
52.65
Forward P/E
-
PEG
14.48
P/S
9.82
P/B
10.41
P/C
-
P/FCF
740.8
Quick Ratio
2.36
Current Ratio
3.56
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
16.13
EPS next Y
-
EPS next Q
-
EPS this Y
7.02%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-3.35%
Revenue last 5Y
9.43%
Revenue Q/Q
10.37%
EPS Q/Q
42.86%
-
-
-
-
SMA20
4.56%
SMA50
-7.47%
SMA100
24.01%
Inst Own
-
Inst Trans
-
ROA
15%
ROE
41%
ROC
0.22%
Gross Margin
48%
Oper. Margin
22%
Profit Margin
19%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
223.15-901.05
52W High
-18.65%
52W Low
+228.7%
RSI
42
Rel Volume
0.3
Avg Volume
241.16K
Volume
73.48K
Perf Week
-10.41%
Perf Month
-13.79%
Perf Quarter
25.68%
Perf Half Y
40.77%
-
-
-
-
Beta
1.059
-
-
Volatility
33.31%, 38.56%
Prev Close
-0.64%
Price
733
Change
-2.53%
NEWGEN.NS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 91.17 | 47.96 | 48.61 | 56.1 | 69.96 | |
Net income per share | 15.01 | 5.28 | 9.14 | 11.83 | 12.66 | |
Operating cash flow per share | 15.01 | 6.54 | 15.59 | 10.28 | 9.79 | |
Free cash flow per share | 4.45 | 3.36 | 14.74 | 9.37 | 8.59 | |
Cash per share | 33.9 | 17.52 | 23.48 | 26.53 | 30.46 | |
Book value per share | 72.96 | 39.86 | 48.11 | 58.44 | 70.16 | |
Tangible book value per share | 72.77 | 39.76 | 48.06 | 57.08 | 69.01 | |
Share holders equity per share | 72.96 | 39.86 | 48.11 | 58.44 | 70.16 | |
Interest debt per share | 12.96 | 8.77 | 1.72 | 2.15 | 3.37 | |
Market cap | 11.3B | 7.3B | 19.58B | 32.33B | 31.37B | |
Enterprise value | 10.54B | 7.4B | 19.07B | 31.57B | 30.72B | |
P/E ratio | 11.06 | 10.03 | 15.48 | 19.68 | 17.8 | |
Price to sales ratio | 1.82 | 1.1 | 2.91 | 4.15 | 3.22 | |
POCF ratio | 11.06 | 8.1 | 9.08 | 22.64 | 23.01 | |
PFCF ratio | 37.32 | 15.77 | 9.6 | 24.85 | 26.24 | |
P/B Ratio | 2.28 | 1.33 | 2.94 | 3.98 | 3.21 | |
PTB ratio | 2.28 | 1.33 | 2.94 | 3.98 | 3.21 | |
EV to sales | 1.7 | 1.12 | 2.83 | 4.05 | 3.15 | |
Enterprise value over EBITDA | 6.41 | 6.02 | 9.39 | 14.28 | 12.48 | |
EV to operating cash flow | 10.31 | 8.22 | 8.84 | 22.11 | 22.53 | |
EV to free cash flow | 34.78 | 16.01 | 9.35 | 24.27 | 25.69 | |
Earnings yield | 0.09 | 0.1 | 0.06 | 0.05 | 0.06 | |
Free cash flow yield | 0.03 | 0.06 | 0.1 | 0.04 | 0.04 | |
Debt to equity | 0.16 | 0.2 | 0.03 | 0.03 | 0.04 | |
Debt to assets | 0.11 | 0.13 | 0.02 | 0.03 | 0.03 | |
Net debt to EBITDA | -0.47 | 0.09 | -0.25 | -0.34 | -0.27 | |
Current ratio | 2.56 | 2.19 | 3.06 | 3.13 | 2.79 | |
Interest coverage | 21.3 | 8.54 | 47.14 | 85.66 | 44.74 | |
Income quality | 0.77 | 0.95 | 1.19 | 0.7 | 0.63 | |
Dividend Yield | 0.01 | 0.03 | 0.01 | 0.01 | 0.01 | |
Payout ratio | 0.16 | 0.35 | 0.11 | 0.15 | 0.18 | |
Sales general and administrative to revenue | 0.05 | 0.05 | 0.07 | 0.06 | 0.07 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0.02 | 0.01 | |
Capex to operating cash flow | -0.7 | -0.49 | -0.05 | -0.09 | -0.12 | |
Capex to revenue | -0.12 | -0.07 | -0.02 | -0.02 | -0.02 | |
Capex to depreciation | -12.03 | -2.2 | -0.58 | -0.72 | -0.68 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0.01 | 0.02 | |
Graham number | 157 | 68.81 | 99.46 | 124.71 | 141.37 | |
ROIC | 0.2 | 0.09 | 0.17 | 0.17 | 0.15 | |
Return on tangible assets | 0.14 | 0.08 | 0.14 | 0.15 | 0.13 | |
Graham Net | 30.23 | 11.72 | 20.53 | 23.93 | 27.3 | |
Working capital | 3.38B | 3.27B | 4.37B | 5.08B | 5.31B | |
Tangible asset value | 4.95B | 5.48B | 6.65B | 7.92B | 9.61B | |
Net current asset value | 3.08B | 2.81B | 3.94B | 4.51B | 4.62B | |
Invested capital | 0.16 | 0.2 | 0.03 | 0.03 | 0.04 | |
Average receivables | 1.59B | 3.37B | 3.37B | 3.41B | 4.2B | |
Average payables | 222.63M | 245.57M | 250.75M | 295.48M | 556.45M | |
Average inventory | -179.12M | -430.1M | -488.77M | -376.27M | -486.11M | |
Days sales outstanding | 187.27 | 196.76 | 172.08 | 170.85 | 178.01 | |
Days payables outstanding | 957.12 | 444.38 | 663.43 | 814.96 | 52.95 | |
Days of inventory on hand | -1.59K | -810.93 | -1.39K | -619.21 | -49.19 | |
Receivables turnover | 1.95 | 1.86 | 2.12 | 2.14 | 2.05 | |
Payables turnover | 0.38 | 0.82 | 0.55 | 0.45 | 6.89 | |
Inventory turnover | -0.23 | -0.45 | -0.26 | -0.59 | -7.42 | |
ROE | 0.21 | 0.13 | 0.19 | 0.2 | 0.18 | |
Capex per share | -10.56 | -3.18 | -0.85 | -0.91 | -1.2 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q3
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 18.3 | 21.9 | 18.06 | 21.02 | 23.2 | |
Net income per share | 3.4 | 5.64 | 2.16 | 3.43 | 4.9 | |
Operating cash flow per share | 0.88 | 1.05 | 0.98 | 0.98 | 0.99 | |
Free cash flow per share | 0.88 | 1.05 | 0.98 | 0.98 | 0.99 | |
Cash per share | 0 | 30.44 | 0 | 48 | 0 | |
Book value per share | 0 | 70.11 | 0 | 74.27 | 0 | |
Tangible book value per share | 0 | 68.97 | 0 | 73.25 | 0 | |
Share holders equity per share | 0 | 70.11 | 0 | 74.27 | 0 | |
Interest debt per share | 0.08 | 3.15 | 0.09 | 2.85 | 0.09 | |
Market cap | 25.09B | 31.39B | 47.3B | 62.8B | 110.91B | |
Enterprise value | 25.09B | 30.74B | 47.3B | 61.97B | 110.91B | |
P/E ratio | 13.26 | 9.98 | 39.22 | 32.86 | 40.57 | |
Price to sales ratio | 9.84 | 10.29 | 18.79 | 21.42 | 34.27 | |
POCF ratio | 203.54 | 214.45 | 347.07 | 458.07 | 803.66 | |
PFCF ratio | 203.54 | 214.45 | 347.07 | 458.07 | 803.66 | |
P/B Ratio | 0 | 3.21 | 0 | 6.06 | 0 | |
PTB ratio | 0 | 3.21 | 0 | 6.06 | 0 | |
EV to sales | 9.84 | 10.08 | 18.79 | 21.13 | 34.27 | |
Enterprise value over EBITDA | 36.73 | 29.47 | 105.99 | 93.08 | 125.75 | |
EV to operating cash flow | 203.54 | 209.99 | 347.07 | 451.98 | 803.66 | |
EV to free cash flow | 203.54 | 209.99 | 347.07 | 451.98 | 803.66 | |
Earnings yield | 0.02 | 0.03 | 0.01 | 0.01 | 0.01 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0 | 0.04 | 0 | 0.04 | 0 | |
Debt to assets | 0 | 0.03 | 0 | 0.03 | 0 | |
Net debt to EBITDA | 0 | -0.63 | 0 | -1.25 | 0 | |
Current ratio | 0 | 2.79 | 0 | 3.56 | 0 | |
Interest coverage | 57.78 | 82.51 | 21.06 | 53.37 | 62.1 | |
Income quality | 0.26 | 0.19 | 0.45 | 0.29 | 0.2 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0.01 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0.01 | 0 | 0.01 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0.05 | 0 | 0 | 0 | |
Graham number | 0 | 94.35 | 0 | 75.66 | 0 | |
ROIC | 0 | 0.08 | 0 | 0.04 | 0 | |
Return on tangible assets | 0 | 0.06 | 0 | 0.03 | 0 | |
Graham Net | 0 | 26.67 | 0 | 39.97 | 0 | |
Working capital | 3.52B | 5.31B | 3.4B | 7.28B | 0 | |
Tangible asset value | 0 | 9.61B | 0 | 10.22B | 0 | |
Net current asset value | 3.52B | 4.62B | 3.4B | 6.62B | 0 | |
Invested capital | 0 | 0.04 | 0 | 0.04 | 0 | |
Average receivables | 1.29B | 2.38B | 2.38B | 1.58B | 1.58B | |
Average payables | 165.45M | 374.19M | 374.19M | 182.02M | 182.02M | |
Average inventory | 714K | -433.88M | -433.88M | 0 | 0 | |
Days sales outstanding | 0 | 140.14 | 0 | 96.94 | 0 | |
Days payables outstanding | 0 | 47.58 | 0 | 20.92 | 0 | |
Days of inventory on hand | 0 | -55.17 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0.64 | 0 | 0.93 | 0 | |
Payables turnover | 0 | 1.89 | 0 | 4.3 | 0 | |
Inventory turnover | 0 | -1.63 | 0 | 0 | 0 | |
ROE | 0 | 0.08 | 0 | 0.05 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
NEWGEN.NS Frequently Asked Questions
What is Newgen Software Technologies Limited stock symbol ?
Newgen Software Technologies Limited is a IN stock and trading under the symbol NEWGEN.NS
What is Newgen Software Technologies Limited stock quote today ?
Newgen Software Technologies Limited stock price is $733 today.
Is Newgen Software Technologies Limited stock public?
Yes, Newgen Software Technologies Limited is a publicly traded company.